203 related articles for article (PubMed ID: 38510236)
1. A protective effect of inflammatory bowel disease on the severity of sclerosing cholangitis.
Stumme F; Steffens N; Steglich B; Mathies F; Nawrocki M; Sabihi M; Soukou-Wargalla S; Göke E; Kempski J; Fründt T; Weidemann S; Schramm C; Gagliani N; Huber S; Bedke T
Front Immunol; 2024; 15():1307297. PubMed ID: 38510236
[TBL] [Abstract][Full Text] [Related]
2. Protective function of sclerosing cholangitis on IBD.
Bedke T; Stumme F; Tomczak M; Steglich B; Jia R; Bohmann S; Wittek A; Kempski J; Göke E; Böttcher M; Reher D; Franke A; Lennartz M; Clauditz T; Sauter G; Fründt T; Weidemann S; Tiegs G; Schramm C; Gagliani N; Pelczar P; Huber S
Gut; 2024 Jun; ():. PubMed ID: 38839272
[TBL] [Abstract][Full Text] [Related]
3. Loss of apical sodium bile acid transporter alters bile acid circulation and reduces biliary damage in cholangitis.
Meadows V; Marakovits C; Ekser B; Kundu D; Zhou T; Kyritsi K; Pham L; Chen L; Kennedy L; Ceci L; Wu N; Carpino G; Zhang W; Isidan A; Meyer A; Owen T; Gaudio E; Onori P; Alpini G; Francis H
Am J Physiol Gastrointest Liver Physiol; 2023 Jan; 324(1):G60-G77. PubMed ID: 36410025
[TBL] [Abstract][Full Text] [Related]
4. Interferon-γ-dependent immune responses contribute to the pathogenesis of sclerosing cholangitis in mice.
Ravichandran G; Neumann K; Berkhout LK; Weidemann S; Langeneckert AE; Schwinge D; Poch T; Huber S; Schiller B; Hess LU; Ziegler AE; Oldhafer KJ; Barikbin R; Schramm C; Altfeld M; Tiegs G
J Hepatol; 2019 Oct; 71(4):773-782. PubMed ID: 31173810
[TBL] [Abstract][Full Text] [Related]
5. Bile acids modulate colonic MAdCAM-1 expression in a murine model of combined cholestasis and colitis.
Gao RY; Shearn CT; Orlicky DJ; Battista KD; Alexeev EE; Cartwright IM; Lanis JM; Kostelecky RE; Ju C; Colgan SP; Fennimore BP
Mucosal Immunol; 2021 Mar; 14(2):479-490. PubMed ID: 33004979
[TBL] [Abstract][Full Text] [Related]
6. Inflammatory bowel disease of primary sclerosing cholangitis: a distinct entity?
Nakazawa T; Naitoh I; Hayashi K; Sano H; Miyabe K; Shimizu S; Joh T
World J Gastroenterol; 2014 Mar; 20(12):3245-54. PubMed ID: 24696608
[TBL] [Abstract][Full Text] [Related]
7. What is the association of primary sclerosing cholangitis with sex and inflammatory bowel disease in Turkish patients?
Bayraktar Y; Arslan S; Saglam F; Uzunalimoglu B; Kayhan B
Hepatogastroenterology; 1998; 45(24):2064-72. PubMed ID: 9951867
[TBL] [Abstract][Full Text] [Related]
8. Contrasting Pattern of Chronic Inflammatory Bowel Disease in Primary and Autoimmune Sclerosing Cholangitis.
Bjarnason I; Hayee B; Pavlidis P; Kvasnovsky C; Scalori A; Sisson G; Charlesworth A; Shaikh H; Bjornsson E; Heneghan MA
EBioMedicine; 2015 Oct; 2(10):1523-7. PubMed ID: 26629548
[TBL] [Abstract][Full Text] [Related]
9. Gut and liver T-cells of common clonal origin in primary sclerosing cholangitis-inflammatory bowel disease.
Henriksen EK; Jørgensen KK; Kaveh F; Holm K; Hamm D; Olweus J; Melum E; Chung BK; Eide TJ; Lundin KE; Boberg KM; Karlsen TH; Hirschfield GM; Liaskou E
J Hepatol; 2017 Jan; 66(1):116-122. PubMed ID: 27647428
[TBL] [Abstract][Full Text] [Related]
10. The microbiota and the gut-liver axis in primary sclerosing cholangitis.
Hov JR; Karlsen TH
Nat Rev Gastroenterol Hepatol; 2023 Mar; 20(3):135-154. PubMed ID: 36352157
[TBL] [Abstract][Full Text] [Related]
11. Gut microbiome in primary sclerosing cholangitis: A review.
Little R; Wine E; Kamath BM; Griffiths AM; Ricciuto A
World J Gastroenterol; 2020 Jun; 26(21):2768-2780. PubMed ID: 32550753
[TBL] [Abstract][Full Text] [Related]
12. Distinctive inflammatory bowel disease phenotype in primary sclerosing cholangitis.
de Vries AB; Janse M; Blokzijl H; Weersma RK
World J Gastroenterol; 2015 Feb; 21(6):1956-71. PubMed ID: 25684965
[TBL] [Abstract][Full Text] [Related]
13. Primary sclerosing cholangitis associated colitis: Characterization of clinical, histologic features, and their associations with liver transplantation.
Aranake-Chrisinger J; Dassopoulos T; Yan Y; Nalbantoglu I
World J Gastroenterol; 2020 Jul; 26(28):4126-4139. PubMed ID: 32821074
[TBL] [Abstract][Full Text] [Related]
14. Downregulation of TGR5 (GPBAR1) in biliary epithelial cells contributes to the pathogenesis of sclerosing cholangitis.
Reich M; Spomer L; Klindt C; Fuchs K; Stindt J; Deutschmann K; Höhne J; Liaskou E; Hov JR; Karlsen TH; Beuers U; Verheij J; Ferreira-Gonzalez S; Hirschfield G; Forbes SJ; Schramm C; Esposito I; Nierhoff D; Fickert P; Fuchs CD; Trauner M; García-Beccaria M; Gabernet G; Nahnsen S; Mallm JP; Vogel M; Schoonjans K; Lautwein T; Köhrer K; Häussinger D; Luedde T; Heikenwalder M; Keitel V
J Hepatol; 2021 Sep; 75(3):634-646. PubMed ID: 33872692
[TBL] [Abstract][Full Text] [Related]
15. Macrophages contribute to the pathogenesis of sclerosing cholangitis in mice.
Guicciardi ME; Trussoni CE; Krishnan A; Bronk SF; Lorenzo Pisarello MJ; O'Hara SP; Splinter PL; Gao Y; Vig P; Revzin A; LaRusso NF; Gores GJ
J Hepatol; 2018 Sep; 69(3):676-686. PubMed ID: 29802947
[TBL] [Abstract][Full Text] [Related]
16. A Gradient of Intestinal Inflammation in Primary Sclerosing Cholangitis.
Wittek A; Steglich B; Casar C; Seiz O; Huber P; Ehlken H; Reher D; Wende S; Bedke T; Kempski J; Böttcher M; Bang C; Thingholm L; Krech T; Lohse AW; Sauter G; Rösch T; Franke A; Schramm C; Gagliani N; Pelczar P; Huber S
Inflamm Bowel Dis; 2024 Jun; 30(6):900-910. PubMed ID: 37540889
[TBL] [Abstract][Full Text] [Related]
17. Primary sclerosing cholangitis (PSC) and inflammatory bowel disease (IBD): a condition exemplifying the crosstalk of the gut-liver axis.
Kim YS; Hurley EH; Park Y; Ko S
Exp Mol Med; 2023 Jul; 55(7):1380-1387. PubMed ID: 37464092
[TBL] [Abstract][Full Text] [Related]
18. Factors associated with major radiological progression of primary sclerosing cholangitis in patients with inflammatory bowel disease.
Azzam N; AlRuthia Y; Alharbi O; Aljebreen A; Almadi M; Loftus EV
Hepatol Int; 2020 Dec; 14(6):1114-1124. PubMed ID: 33369708
[TBL] [Abstract][Full Text] [Related]
19. Characterization of the gut microbiota in patients with primary sclerosing cholangitis compared to inflammatory bowel disease and healthy controls.
Ostadmohammadi S; Azimirad M; Houri H; Naseri K; Javanmard E; Mirjalali H; Yadegar A; Sadeghi A; Asadzadeh Aghdaei H; Zali MR
Mol Biol Rep; 2021 Jul; 48(7):5519-5529. PubMed ID: 34304365
[TBL] [Abstract][Full Text] [Related]
20. The gut microbiota, bile acids and their correlation in primary sclerosing cholangitis associated with inflammatory bowel disease.
Torres J; Palmela C; Brito H; Bao X; Ruiqi H; Moura-Santos P; Pereira da Silva J; Oliveira A; Vieira C; Perez K; Itzkowitz SH; Colombel JF; Humbert L; Rainteau D; Cravo M; Rodrigues CM; Hu J
United European Gastroenterol J; 2018 Feb; 6(1):112-122. PubMed ID: 29435321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
